Brief: FDA Adds Warning About Rare Occurrence Of Serious Liver Injury With Use Of Veozah (Fezolinetant) For Hot Flashes Due To Menopause
12/09/2024 18:15
Sept 12 (Reuters) - FDA:
* FDA ADDS WARNING ABOUT RARE OCCURRENCE OF SERIOUS LIVER
INJURY
WITH USE OF VEOZAH (FEZOLINETANT) FOR HOT FLASHES DUE TO
MENOPAUSE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn